ADVANCED PHARMACOLOGY FOR
m m mm
PRESCRIBERS 1ST EDITION BY LUO K
m m m m m
AYINGO TEST BANK | 2024 UPDATE
m m m m m
, Table of Contents
m m
Chapterm 1:mAn mIntroduction mto mEvidence-Based mClinicalm PracticemGuidelines ........................................ 3
Chapterm 2:mPharmacokineticsm /Chapter3:mPharmacodynamics ..............................................................13
Chapter4:mPharmacogeneticsm and mPharmacogenomics .........................................................................25
Chapterm 5:mPharmacology mAcrossm themLifemSpan ................................................................................30
Chapterm 6:mDrug-Therapy mPrescribingmin mSpecialmPopulations.............................................................36
Chapterm 7:mDrugmDevelopmentm and mApproval ....................................................................................45
Chapterm8-Chapterm10:mFoundationsmof mPrescription mWritingmChapterm9:mResponsibleControlled-
Substance mPrescribingmChapterm10:mAntibiotic mStewardship ................................................................ 51
Chapterm 11:mApplied mCalculationsmform Prescribing..............................................................................58
Chapterm12-:mPromotingmAdherence mWith mPharmacotherapy mII:mSystem-Specific mand mPatient-
Focused mPrescribingmChapterm13:mPharmacotherapymformEar,mNose,mMouth,mandThroatmConditionsm/Chapt
erm14:mPharmacotherapy mformEyemConditions...................................................................................... 67
Chapterm 15:mPharmacotherapy mform Skin mConditions ............................................................................74
Chapterm 16:mPharmacotherapy mform Neurologic m Conditions ..................................................................81
Chapterm 17:mPharmacotherapy mform Cardiovascularm Conditions ............................................................94
Chapterm 18:mPharmacotherapy mformRespiratory mConditions................................................................106
Chapterm19:mPharmacotherapymformGastrointestinalmConditionsmand mConditionsmRequiringNutritionalmSup
port ............................................................................................................................................... 117
Chapterm 20:mPharmacotherapy mform Genitourinary mConditions ............................................................128
Chapterm21:mPharmacotherapy mform Renal,mAcid–Base,m Fluid,mand mElectrolytemDisorders.....................133
Chapterm 22:mPharmacotherapy mform Musculoskeletalmand mRheumatologicm Conditions ..........................146
Chapterm 23:mTherapeutic m Applicationsm of mImmunology mand mVaccines...............................................158
Chapterm 24:mPharmacotherapy mform EndocrinemDisorders....................................................................163
Chapterm25:mPharmacotherapy mformHematologic m Disorders................................................................174
Chapterm 26:mHematology/Oncology mand mSupportivemCaremform themNononcologist...............................190
Chapterm 27:mPharmacotherapy mRelated mto mWomen’smHealth mConditions ............................................196
Chapterm 28:mPharmacotherapy mRelated mto mMen’smHealth mConditions .................................................211
Chapterm 29:mPharmacotherapym Related mto mTransgendermCare ............................................................217
Chapterm 30:mAntimicrobialmPharmacotherapy....................................................................................224
Chapterm 31:mAntiretroviralmPharmacotherapy ....................................................................................235
Chapterm32:mPsychopharmacology mandmIntegrativemHealth:mCombined mTreatmentmofPsychiatric mandmNeur
ocognitive mConditions .................................................................................................................... 247
Chapterm 33:mPharmacotherapy mform Pain mManagement .......................................................................257
Chapterm 34:mSubstance mUsemDisorderm III:mHealth mPromotion mand mMaintenance ..................................267
Chapterm 35:mOver-the-Counterm Medications......................................................................................283
Chapterm36:mPharmacotherapy mform Obesity .......................................................................................291
,Chapterm1:mAnmIntroduction mtomEvidence-Based mClinicalmPractice mGuidelines
MULTIPLEmCHOICE
• Whatmismthemprimary mpurpose m of mthem nursingm assessment?
A. Identifyingm underlyingm pathologic m conditions
B. Assistingm them physician min midentifyingm medicalm conditions
C. Determiningm thempatientsmmentalmstatus
D. Exploringm patientm responsesm to m health m problems
ANS:mD
Amnursingmassessmentmismdonemto midentify mthempatientsmresponse mto mhealth m
problems.mDuringmthemnursingmassessmentmphase,mamcomprehensive minform
ation mbasemismdeveloped mthrough mamphysicalmexamination, mnursingmhistory,m
medication mhistory,mand mprofessionalmobservation. mIdentifyingmunderlyingm
pathologic mconditionsmand massistingmthemphysician min midentifyingmmedicalm
conditionsmismnotmpartmof mthemnursingmprocess.mDeterminingmthempatientsm m
entalmstatusm ismonempartm of mthem nursingm assessment, m butm itm ism notmthempri
mary mpurpose.
DIF:mCognitivemLevel:mComprehension
mREF:mdm m36 mOBJ:m1 m|m3 mTOP:mNursin
gmProcessmStep:mAssessment
MSC:mNCLEXm ClientmNeedsm Category:m Health mPromotion mand m Maintenance
• Whatmismthembasism of mthemNANDAmIm taxonomy?
A. Functionalm health mpatterns
B. Human mresponse m patterns
C. Basicm human m needs
D. Pathophysiologic m needs
ANS:mB
Them NANDAm Im taxonomy m identifiesm human m response m patterns.mFuncti
onalmcomponentsmof mhealth mpatternsmaremlimited mto mactivity,mfluid mvolume,
mnutrition, mself mcare, mand msensory mperception. mBasic mhuman mneeds mcompri
semlessmthan mmerely mhealth mpatterns.m Pathophysiologic mneedsm aremnotmpar
tmof mthemscopemof mNANDAmI.
, DIF:mCognitivemLevel:mKnowledge mRE
F:mpp.m37-38 mOBJ:m5 mTOP:
NursingmProcessmStep:mDiagnosis
MSC:mNCLEXm Clientm Needsm Category:mPhysiologicalm Integrity
• Which mtask mismincluded m in mthemassessmentmstep m of mthem nursingm process?
A. Establishingm patientm goals/outcomes
B. Implementingm them nursingmcarem plan m (NCP)
C. Measuringm goal/outcome m achievement
D. Collectingm and m communicatingm data
ANS:mD
Datamaremcollected mand mcommunicated min mthemassessmentmphasemofmthemnur
singmprocess.mEstablishingmgoalsmismthemfunction mof mplanning.
ImplementingmthemNCPmismthemfunction mof mimplementation. mMeasuringmout
comemachievementmismthemfunction mof mevaluation.
DIF:mCognitive mLevel:mComprehensio
n mREF:mdmm36 mOBJ:m2 m|m3 mTOP:mNursi
ngmProcessmStep:mAssessment
MSC:mNCLEXm ClientmNeedsm Category:m Health mPromotion mand m Maintenance
• Which mstatementm regardingm nursingm diagnosesm ism accurate?
a. Nursingmdiagnosesmremain mthemsamem formasm longmasmthemdisease m ism present.
b. Nursingm diagnosesm aremwritten mto midentify mdisease mstates.
c. Nursingm diagnosesmdescribe m patientmproblemsmthatm nursesm treat.
d. Nursingmdiagnosesm identify mcausesm related mto millness.
ANS:mC
Diagnostic mstatementsmidentify mproblemsmamnursemismindependently mablemto
mtreatmwithin mthe mscope mof mprofessionalmpractice. mNursingmdiagnoses mvary m
with mthemchangingmcondition mof mthempatient.mThemresponse mpatternsmaremun
iquemto mthempatientmand maremnotmdisease mspecific.mNursingmdiagnosesmdescr
ibemthempatientsmhuman mresponse mpattern.
DIF:m Cognitive m Level:m Comprehension
m m mm
PRESCRIBERS 1ST EDITION BY LUO K
m m m m m
AYINGO TEST BANK | 2024 UPDATE
m m m m m
, Table of Contents
m m
Chapterm 1:mAn mIntroduction mto mEvidence-Based mClinicalm PracticemGuidelines ........................................ 3
Chapterm 2:mPharmacokineticsm /Chapter3:mPharmacodynamics ..............................................................13
Chapter4:mPharmacogeneticsm and mPharmacogenomics .........................................................................25
Chapterm 5:mPharmacology mAcrossm themLifemSpan ................................................................................30
Chapterm 6:mDrug-Therapy mPrescribingmin mSpecialmPopulations.............................................................36
Chapterm 7:mDrugmDevelopmentm and mApproval ....................................................................................45
Chapterm8-Chapterm10:mFoundationsmof mPrescription mWritingmChapterm9:mResponsibleControlled-
Substance mPrescribingmChapterm10:mAntibiotic mStewardship ................................................................ 51
Chapterm 11:mApplied mCalculationsmform Prescribing..............................................................................58
Chapterm12-:mPromotingmAdherence mWith mPharmacotherapy mII:mSystem-Specific mand mPatient-
Focused mPrescribingmChapterm13:mPharmacotherapymformEar,mNose,mMouth,mandThroatmConditionsm/Chapt
erm14:mPharmacotherapy mformEyemConditions...................................................................................... 67
Chapterm 15:mPharmacotherapy mform Skin mConditions ............................................................................74
Chapterm 16:mPharmacotherapy mform Neurologic m Conditions ..................................................................81
Chapterm 17:mPharmacotherapy mform Cardiovascularm Conditions ............................................................94
Chapterm 18:mPharmacotherapy mformRespiratory mConditions................................................................106
Chapterm19:mPharmacotherapymformGastrointestinalmConditionsmand mConditionsmRequiringNutritionalmSup
port ............................................................................................................................................... 117
Chapterm 20:mPharmacotherapy mform Genitourinary mConditions ............................................................128
Chapterm21:mPharmacotherapy mform Renal,mAcid–Base,m Fluid,mand mElectrolytemDisorders.....................133
Chapterm 22:mPharmacotherapy mform Musculoskeletalmand mRheumatologicm Conditions ..........................146
Chapterm 23:mTherapeutic m Applicationsm of mImmunology mand mVaccines...............................................158
Chapterm 24:mPharmacotherapy mform EndocrinemDisorders....................................................................163
Chapterm25:mPharmacotherapy mformHematologic m Disorders................................................................174
Chapterm 26:mHematology/Oncology mand mSupportivemCaremform themNononcologist...............................190
Chapterm 27:mPharmacotherapy mRelated mto mWomen’smHealth mConditions ............................................196
Chapterm 28:mPharmacotherapy mRelated mto mMen’smHealth mConditions .................................................211
Chapterm 29:mPharmacotherapym Related mto mTransgendermCare ............................................................217
Chapterm 30:mAntimicrobialmPharmacotherapy....................................................................................224
Chapterm 31:mAntiretroviralmPharmacotherapy ....................................................................................235
Chapterm32:mPsychopharmacology mandmIntegrativemHealth:mCombined mTreatmentmofPsychiatric mandmNeur
ocognitive mConditions .................................................................................................................... 247
Chapterm 33:mPharmacotherapy mform Pain mManagement .......................................................................257
Chapterm 34:mSubstance mUsemDisorderm III:mHealth mPromotion mand mMaintenance ..................................267
Chapterm 35:mOver-the-Counterm Medications......................................................................................283
Chapterm36:mPharmacotherapy mform Obesity .......................................................................................291
,Chapterm1:mAnmIntroduction mtomEvidence-Based mClinicalmPractice mGuidelines
MULTIPLEmCHOICE
• Whatmismthemprimary mpurpose m of mthem nursingm assessment?
A. Identifyingm underlyingm pathologic m conditions
B. Assistingm them physician min midentifyingm medicalm conditions
C. Determiningm thempatientsmmentalmstatus
D. Exploringm patientm responsesm to m health m problems
ANS:mD
Amnursingmassessmentmismdonemto midentify mthempatientsmresponse mto mhealth m
problems.mDuringmthemnursingmassessmentmphase,mamcomprehensive minform
ation mbasemismdeveloped mthrough mamphysicalmexamination, mnursingmhistory,m
medication mhistory,mand mprofessionalmobservation. mIdentifyingmunderlyingm
pathologic mconditionsmand massistingmthemphysician min midentifyingmmedicalm
conditionsmismnotmpartmof mthemnursingmprocess.mDeterminingmthempatientsm m
entalmstatusm ismonempartm of mthem nursingm assessment, m butm itm ism notmthempri
mary mpurpose.
DIF:mCognitivemLevel:mComprehension
mREF:mdm m36 mOBJ:m1 m|m3 mTOP:mNursin
gmProcessmStep:mAssessment
MSC:mNCLEXm ClientmNeedsm Category:m Health mPromotion mand m Maintenance
• Whatmismthembasism of mthemNANDAmIm taxonomy?
A. Functionalm health mpatterns
B. Human mresponse m patterns
C. Basicm human m needs
D. Pathophysiologic m needs
ANS:mB
Them NANDAm Im taxonomy m identifiesm human m response m patterns.mFuncti
onalmcomponentsmof mhealth mpatternsmaremlimited mto mactivity,mfluid mvolume,
mnutrition, mself mcare, mand msensory mperception. mBasic mhuman mneeds mcompri
semlessmthan mmerely mhealth mpatterns.m Pathophysiologic mneedsm aremnotmpar
tmof mthemscopemof mNANDAmI.
, DIF:mCognitivemLevel:mKnowledge mRE
F:mpp.m37-38 mOBJ:m5 mTOP:
NursingmProcessmStep:mDiagnosis
MSC:mNCLEXm Clientm Needsm Category:mPhysiologicalm Integrity
• Which mtask mismincluded m in mthemassessmentmstep m of mthem nursingm process?
A. Establishingm patientm goals/outcomes
B. Implementingm them nursingmcarem plan m (NCP)
C. Measuringm goal/outcome m achievement
D. Collectingm and m communicatingm data
ANS:mD
Datamaremcollected mand mcommunicated min mthemassessmentmphasemofmthemnur
singmprocess.mEstablishingmgoalsmismthemfunction mof mplanning.
ImplementingmthemNCPmismthemfunction mof mimplementation. mMeasuringmout
comemachievementmismthemfunction mof mevaluation.
DIF:mCognitive mLevel:mComprehensio
n mREF:mdmm36 mOBJ:m2 m|m3 mTOP:mNursi
ngmProcessmStep:mAssessment
MSC:mNCLEXm ClientmNeedsm Category:m Health mPromotion mand m Maintenance
• Which mstatementm regardingm nursingm diagnosesm ism accurate?
a. Nursingmdiagnosesmremain mthemsamem formasm longmasmthemdisease m ism present.
b. Nursingm diagnosesm aremwritten mto midentify mdisease mstates.
c. Nursingm diagnosesmdescribe m patientmproblemsmthatm nursesm treat.
d. Nursingmdiagnosesm identify mcausesm related mto millness.
ANS:mC
Diagnostic mstatementsmidentify mproblemsmamnursemismindependently mablemto
mtreatmwithin mthe mscope mof mprofessionalmpractice. mNursingmdiagnoses mvary m
with mthemchangingmcondition mof mthempatient.mThemresponse mpatternsmaremun
iquemto mthempatientmand maremnotmdisease mspecific.mNursingmdiagnosesmdescr
ibemthempatientsmhuman mresponse mpattern.
DIF:m Cognitive m Level:m Comprehension
